Literature DB >> 4378395

The importance of type IV hyperlipoproteinemia as a predisposing factor in coronary artery disease.

A F Salel, K Riggs, D T Mason, E A Amsterdam, R Zelis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4378395     DOI： 10.1016/0002-9343(74)90167-3

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  7 in total

1.  Hyperlipidaemia in Scotland and the role of drug treatment.

Authors:  J L Third; W F Bremner; T D Lawrie
Journal:  Proc R Soc Med       Date:  1976

2.  Relation between extent of coronary artery disease and severity of hyperlipoproteinaemia.

Authors:  R G Murray; A Tweddel; J L Third; I Hutton; W S Hillis; A R Lorimer; T D Lawrie
Journal:  Br Heart J       Date:  1975-12

Review 3.  Triglycerides and disease.

Authors:  C A Seymour; C D Byrne
Journal:  Postgrad Med J       Date:  1993-09       Impact factor: 2.401

4.  Should studies of patients undergoing coronary angiography be used to evaluate the role of behavioral risk factors for coronary heart disease?

Authors:  T G Pickering
Journal:  J Behav Med       Date:  1985-09

5.  [Diurnal patterns of plasma lipids and lipoproteins in primary endogenous hypertriglyceridemia (type IV-hyperlipoproteinemia) (author's transl)].

Authors:  G Schlierf; P Oster; D Seidel; H Raetzer; B Schellenberg; C C Heuck; R L Wicklein
Journal:  Klin Wochenschr       Date:  1977-02-15

6.  Coronary artery ectasia--a variant of occlusive coronary arteriosclerosis.

Authors:  R H Swanton; M L Thomas; D J Coltart; B S Jenkins; M M Webb-Peploe; B T Williams
Journal:  Br Heart J       Date:  1978-04

7.  Inhibition of lymphoproliferation by hyperlipoproteinemic plasma.

Authors:  C C Waddell; O D Taunton; J J Twomey
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.